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In his excellent Review, David Balding describes the statistical approaches to population association studies as well as the constraints that apply to each type of data analysis 1 . We would like to comment on two points that were raised. First, we believe that exploring haplotype-phenotype associations may be of greater value than estimated in the Review. Second, the logarithmic data transformation that the author recommends be carried out before linear regression analysis could lead to false conclusions about genotype-phenotype associations. The reasoning behind our statements is explained below.
Concerning haplotype-based phenotype analysis, take the example of two loci (A and B); each has two alleles, A_A′ and B_B′, with minor allele frequencies of 0.31 and 0.4, respectively (FIG. 1) . Let us assume that allele A′ has one-third the activity of A and that B′ has 60% higher activity than B. The activity of the haplotypes AB, AB′, A′B and A′B′ would thus be 100%, 160%, 33.3% and 53.3%, respectively, as depicted on the righthand side of Although this case is hypothetical, it illustrates a documented example: the polymorphism analysis of SLCO1B1 (solute carrier organic anion transporter family, member 1B1) resulted in the year-long assumption that a specific polymorphism in this gene was non-functional 2 . The situation was clarified only on haplotype-based phenotypic analysis 3 . Therefore, we do not completely agree with David Balding that haplotype-phenotype analysis provides no advantage over the polymorphism-wise analysis 1 . In fact, we believe that haplotype-based phenotype association analysis should routinely complement polymorphism analysis.
The second point concerns data transformation. Following standard practice in statistics, David Balding recommends that phenotypic data that are not normally distributed should be logarithmically transformed before linear regression for genotype-phenotype analysis 1 . However, such data transformation alters the shape of a relationship between the number of certain alleles and the phenotype (FIG. 2) . Linear regression analysis might fail to detect some linear gene-dose-phenotype relationships (FIG. 2, top) or, conversely, some non-linear relationships will appear to be significant (FIG. 2, bottom) . The extent of both effects depends on the particular data set and the kind of data transformation used. Thus, we would usually discourage data transformation before applying linearization methods in genetics and pharmacogenetics.
